20355 Wolfgang Bauer/Charles Mackenzie: Cancer detection via determination of fractal cell dimension. Internet ca. 1995, 5p. H. Beug/T. Graf: Co-operation between viral oncogenes in avian erythroid and myeloid leukemia. Eur. J. Clin. Inv. 19 (1989), 491-... 18463 Ravi Bhatia/.../Stephen Forman: Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101 (2003), 4701-4707. 18395 D. Bonnet: Cancer stem cells - AMLs show the way. Biochem. Soc. Trans. 33/6 (2005), 1531-1533. 17569 George Calin/.../Manuela Ferracin/.../Massimo Negrini/Carlo Croce: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Nat. Ac. Sci. USA 101/32 (2004), 11755-11760. 17567 George Calin/Manuela Ferracin/.../Massimo Negrini/Carlo Croce: A microRNA signature associated with prognosis and progression of chronic lymphoblastic leukemia. New England J. Med. 353 (2005), 1793-1801. 21303 Sabina Chiaretti/.../Robin Foa: Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 103 (2004), 2771-2778. 18462 Su Chu/.../Ravi Bhatia: Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myeologenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment. Blood 105/5 (2005), 2093-2098. 18407 Caroline Colijn/Michael Mackey: A mathematical model of hematopoiesis I. Periodic chronic myeologenous leukemia. J. Theor. Biol. 237 (2005), 117-132. S. Collins/M. Groudine: Amplification of endogenous MYC-related DNA sequences in a human myeoloid leukemia cell line. Nature 298 (1982), 679-... R. Craig/A. Bloch: Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced to differentiate with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 44 (1984), 442-... 18460 Michael Deininger: Management of early stage disease. Am. Soc. Haem. Education Book 2005, 174-182. CML. 18457 Michael Deininger/Elisabeth Buchdunger/Brian Druker: The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105 (2005), 2640-2653. 18458 Micheal Deininger/Brian Druker: Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol. Rev. 55 (2003), 401-423. 18475 Michael Deininger/John Goldman/Junia Melo: The molecular biology of chronic myeloid leukemia. Blood 96 (2000), 3343-3356. 18477 Lucy Elrick/Heather Jorgensen/Joanne Mountford/Tessa Holyoake: Punish the parent, not the progeny. Blood 105 (2005), 1862-1866. G. Feuer/I. Chen: Mechanisms of human T-cell leukemia virus-induced leukemogenesis. Biochim. Biophys. Acta 1114 (1992), 223-... P. Fialkow a.o.: Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58 (1981), 158-163. 4940 Roberto Foa'/Felice Gavosto: Ruolo del laboratorio nella diagnosi e nella cura delle leucemie. 2 Le Scienze, 65-70. 21472 Jasmine Foo/.../Franziska Michor: Eradication of chronic myeloid leukemia stem cells - a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLOS Comp. Biol. 5/9 (2009), 11p. A. Friedman: Regulation of immature myeloid cell differentiation by PEBP2/CBF, MYB, C/EBP and ETS family members. Curr. Top. Microbiol. Imm. 211 (1996), 149-... Sergio Giralt a.o.: Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. New England J. Med. 329 (1993), 757-761. Filgrastim may be effective in selected cases of leukemic relapse after allogeneic bone marrow transplantation. F. Grignani: The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursors. Cell 74 (1993), 423-... 9124 Paul Harrison/Chris Bartholomew: Leukaemia studies. Beatson, Internet 1996. J. Licht a.o.: Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17) associated acute promyelocytic leukemia. Oncogene 12 (1996), 323-... 20454 Arcangelo Liso/.../Franziska Michor/Brunangelo Falini: A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1). Haematologica 93 (2008), 1219-1226. P. Liu a.o.: Fusion between transcription factor CBF beta/PEBP2beta and a myosin heavy chain in acute myeloid leukemia. Science 261 (1993), 1041-... 11851 A. Thomas Look: Oncogenic transcription factors in the human acute leukemias. Science 7 November 1997, 1059-1064. 4941 Alberto Marmont du Haut Champ: Il trapianto di midollo in oncoematologia. 2 Le Scienze, 71-81. 9368 Bonnie McDonald: Bonnie's story. Internet 1996. Myeolofibrosis. 18446 Franziska Michor: CML blast crisis arises from progenitors. Internet 2007, 18p. 18530 Franziska Michor: Reply - the long term response to imatinib treatment of CML. Brit. J. Cancer 96 (2007), 679-680. 18605 Franziska Michor: Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia. Trends. Pharm. Sci. ... (2007), 3p. 18383 Franziska Michor/Yoh Iwasa/Martin Nowak: The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc. Nat. Ac. Sci. USA 103 (2006), 14931-14934. 14515 Clara Migliavacca: Leucemia - speranza in tempi brevi. Fondamentale gennaio 2001, 12-15. R. Miller: Persons with exceptionally high risk of leukemia. Cancer Res. 27 (1967), 2420-2423. D. Milojkovic/J. Apperley: State-of-the-art in the treatment of chronic myeloid leukaemia. Curr. Op. Oncol. 20 (2008), 112-121. 15713 Robert Modre-Osprian a.o.: DNA-chip analysis for acute lymphatic leukemia. Project UMIT-TKFI-TUG 2003, 1p. 15714 Robert Modre-Osprian a.o.: Patient database for acute lymphatic leukemia. Project UMIT-TKFI-TUG 2003, 1p. F. Moreau-Gachelin/A. Tavitian/P. Tambourin: Spi-I is a putative oncogene in virally induced murine erythroleukaemia. Nature 331 (1988), 277-... 18474 Thomas O'Hare/Amie Corbin/Brian Druker: Targeted CML therapy - controlling drug resistance, seeking cure. Curr. Op. Gen. Dev. 16 /1 (2006), 92-99. T. Okuda a.o.: AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996), 321-... 3659 Guido Paolucci/Vico Vecchi: Strategie terapeutiche per la leucemia linfoblastica acuta infantile. 2 Le Scienze, 127-132. 18684 Dietmar Pfeifer/.../Jens Timmer/Hendrik Veelken: Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 109/3 (2007), 1202-1210. 9367 Ian Pragnell/Gerry Graham: The control of stem cell proliferation. Internet 1996. 21299 Johannes Rainer: Identification of glucocorticoid regulated microRNAs in human acute lymphoblastic leukemia cells. Dissertation TU Graz 2007, 111p. 18499 D. Rea/.../P. Rousselot: High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia. Leukemia 20 (2006), 400-403. R. Redner a.o.: The t(5;17) translocation in acute promyelocytic leukemia generates a nucleophosmin-RARalpha fusion transcript. Blood 84 (1994), 1486-... 19445 Julien Reinhard: Lettre to Daniel Vasella. Internet 2006, 6p. 18473 Ingo Roeder/.../Markus Loeffler: Dynamic modeling of imatinib-treated chronic myeloid leukemia - functional insights and clinical implications. Nature Med. 12/10 (2006), 1181-1184. E. Scott a.o.: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994), 1573-... Lorna Secker-Walke: Cytogenetics of acute lymphoblastic leukemia. Chapman & Hall 1997. 0-41210761-9. $90. 18503 Neil Shah/.../Charles Sawyers: Overriding Imatinib resistance with a novel ABL kinase inhibitor. Science 305 (2004), 399-401. H. de The' a.o.: The t(15:17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347 (1990), 558-... L. Tsai/L. Nanu/R. Smith/Brad Ozanne: Over expression of c-fos in a human pre-B cell acute lymphocytic leukaemia derived cell line. Oncogene 6 (1991), 81-88. L. Tsai a.o.: Expression of platelet derived growth factor and its receptors by two pre-B acute lymphocytic leukaemia cell lines. Blood 83 (1994), 51-55. 15681 Kimmo Virtaneva a.o.: Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc. Nat. Ac. Sci. USA 98 (2001), 1124-1129. K. Weis a.o.: Retinoic acid regulates aberrant nuclear localization of PML-RAR-alpha in acute promyeolocytic leukemia cells. Cell 76 (1994), 345-... 18478 Ellen Weisberg/.../James Griffin: Characterization of AMN107, a selective inhibitor of wild-type and mutant Bcr-Abl. Cancer Cell 7 (2005), 129-141. 19344 Dominik Wodarz: Stem cell regulation and the development of blast crisis in chronic myeloid leukemia - implications for the outcome of imatinib treatment and discontinuation. Med. Hypoth. ... (2007), 9p. 18449 Dominik Wodarz/Natalia Komarova: Emergence and prevention of resistance against small molecule inhibitors. Sem. Cancer Biol. 15 (2005), 506-514. 9074 ZZ: Informationen zum Thema Blutkrebs. Öst. Krebshilfe, Internet 1996. 18456 ZZ: Imatinib. Wikipedia 2007, 2p. 19391 ZZ: [Dr. Stefan Schmidt erhält den Otto-Seibert-Preis.] Med. Univ. Innsbruck Juni 2007, 1p.